单核细胞趋化蛋白-1对67例全身炎症反应综合征患者的诊断价值

doi:10.6040/j.issn.1671-7554.0.2021.0771

摘要/Abstract

摘要： 目的评估单核细胞趋化蛋白-1(MCP-1)在全身炎症反应综合征(SIRS)中的诊断价值。方法前瞻性研究。收集天津医科大学第二医院重症监护病房(ICU)、泌尿外科及胃肠外科于2020年8月至2021年4月收住院的67例经诊断符合SIRS的患者作为病例组,对照组为同期体检人员44例。采用酶联免疫吸附法(ELISA)检测病例组与对照组血清中的MCP-1浓度并比较其差异。将病例组按是否存在多器官功能障碍(MODS)分为MODS组(n=26)和非MODS组(n=41),比较血清MCP-1浓度,绘制受试者工作曲线,评价血清MCP-1对SIRS伴MODS的诊断效能。根据患者临床表现及检测结果,将患者分为脓毒症组(n=15)和非脓毒症组(n=52),比较两组间血清MCP-1浓度。结果 SIRS患者血清MCP-1中位水平为180.2(90.9~407.4)pg/mL,对照组血清中位水平为53.4(40.2~83.7)pg/mL(P<0.001)。SIRS患者中MODS组血清MCP-1中位水平为426.2(150.1~733.6)pg/mL,非MODS组血清MCP-1中位水平为135.0(55.6~236.1)pg/mL(P<0.001),以血清MCP-1为变量对SIRS伴MODS诊断效能的ROC曲线下面积为0.74,最大约登指数对应的血清MCP-1临界值为176.0 pg/mL,敏感度为76.9%,特异性为65.9%。脓毒症组与非脓毒症组血清MCP-1比较差异无统计学意义(P=0.832)。结论 SIRS患者血清MCP-1检测对MODS具有辅助诊断价值,但不能作为SIRS进展为脓毒症的预测指标。

关键词: 全身炎症反应综合征, 脓毒症, 单核细胞趋化蛋白-1, 最大约登指数

Abstract: Objective To evaluate the diagnostic value of monocyte chemo-attractant protein-1(MCP-1)in systemic inflammatory response syndrome(SIRS). Methods In this prospective study, 67 SIRS patients who were admitted to the Intensive Care Unit(ICU), Department of Urology, and Department of Gastrointestinal Surgery in the Second Hospital of Tianjin Medical University during Aug. 2020 and Apr. 2021 were enrolled in the case group, and 44 people who came for physical examination were included in the control group. Enzyme-linked immunosorbent assay(ELISA)was used to detect the serum concentration of MCP-1 and the difference was compared. According to the presence of multiple organ dysfunction(MODS), the case group was subdivided into MODS group(n=26)and non-MODS group(n=41), and the serum concentration of MCP-1 was compared. The receiver operating characteristic(ROC)curve was drawn to evaluate the diagnostic efficacy of serum MCP-1 for SIRS with MODS. According to the clinical symptoms and test results, the patients were divided into the sepsis group(n=15)and non-sepsis group(n=52), and the serum concentration of MCP-1 was compared. Results The median serum MCP-1 level was 180.2(90.9-407.4)pg/mL in SIRS patients and 53.4(40.2-83.7)pg/mL in controls(P<0.001), 426.2(150.1-733.6)pg/mL in MODS group and 135.0(55.6-236.1)pg/mL in non-MODS group(P<0.001). When serum MCP-1 served as the variable, the area under the ROC curve(AUC)for the diagnostic efficacy of SIRS with MODS was 0.74, the cut-off value of serum MCP-1 corresponding to the maximum Youden index was 176.0 pg/mL, the sensitivity was 76.9% and the specificity was 65.9%. There was no significant difference in serum MCP-1 level between sepsis group and non-sepsis group(P=0.832). Conclusion Detection of serum MCP-1 level in SIRS patients has an auxiliary diagnostic value for MODS, but it cannot be used as a predictor of sepsis in SIRS patients.

Key words: Systemic inflammatory response syndrome, Sepsis, Monocyte chemo-attractant protein-1, Maximum Youden index

中图分类号:

R459.7

高金梅,黄映波,冯珍珍. 单核细胞趋化蛋白-1对67例全身炎症反应综合征患者的诊断价值[J]. 山东大学学报 (医学版), 2021, 59(10): 77-81.

GAO Jinmei, HUANG Yingbo, FENG Zhenzhen. Detection of serum MCP-1 in 67 patients with systemic inflammatory response syndrome[J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 77-81.

参考文献

[1] Oh H, Bae E, Lim S, et al. Temporal changes in physiological parameters of systemic inflammatory response syndrome during the three days prior to a diagnosis of sepsis: a case-control study [J]. Clin Nurs, 2016, 25(21-22): 3176-3188.
[2] Staubli SM, Schäfer J, Rosenthal R, et al. The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis [J]. Sci Rep, 2019, 9(1): 18340. doi: 10.1038/s41598-019-54910-8.
[3] Shafik S, Mallick S, Fogel J, et al. The utility of systemic inflammatory response syndrome(SIRS)for diagnosing sepsis in the immediate postpartum period [J]. J Infect Public Health, 2019, 12(6): 799-802.
[4] Kaukonen KM, Bailey M, Pilcher D, et al. The systemic inflammatory response syndrome criteria and their differential association with mortality [J]. J Crit Care, 2018, 8(46): 29-36.
[5] Jacome T, Tatum D. Systemic inflammatory response syndrome(SIRS)score independently predicts poor outcome in isolated traumatic brain injury [J]. Neurocrit Care, 2018, 28(1): 110-116.
[6] Selsted ME, Brown DM, DeLange RJ, et al. Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages [J]. J Biol Chem, 1983, 258(23): 14485-14489.
[7] Gruber HE, Hoelscher GL, Ingram JA, et al. Proinflammatory cytokines modulate the chemokine CCL2(MCP-1)in human annulus cells in vitro: CCL2 expression and production [J]. Exp Mol Pathol, 2015, 98(1): 102-105.
[8] Chen ZY, Wang XY, Yang YM, et al. LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial-mesenchymal transition through miR-124-3p/MCP-1 [J]. Gene Ther, 2020, 28. doi: 10.1038/s41434-020-0176-2.
[9] Hu Q, Myers M, Fang W, et al. Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion [J]. Biol Open, 2019, 8(7): bio040873. doi: 10.1242/bio.040873.
[10] Martinovic I, Abegunewardene N, Seul M, et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease [J]. Circ J, 2005, 69(12): 1484-1489.
[11] Sun X, Wang T, Cai D, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia [J]. Cytokine Growth Factor Rev, 2020, 53: 38-42. doi: 10.1016/j.cytogfr.2020.04.002.
[12] Cavaillon JM, Giamarellos-Bourboulis EJ. Immunosuppression is inappropriately qualifying the immune status of septic and SIRS patients [J]. Shock, 2019, 52(3): 307-317.
[13] Zhu T, Liao X, Feng T, et al. Plasma monocyte chemoattractant protein 1 as a predictive marker for sepsis prognosis: a prospective cohort study [J]. Tohoku J Exp Med, 2017, 241(2): 139-147.
[14] Li YT, Wang YC, Lee HL, et al. Monocyte chemoattractant protein-1, a possible biomarker of multiorgan failure and mortality in ventilator-associated pneumonia [J]. Int J Mol Sci, 2019, 20(9): 2218. doi: 10.3390/ijms20092218.
[15] Gaski GE, Metzger C, McCarroll T, et al. Early Immunologic response in multiply injured patients with orthopaedic injuries is associated with organ dysfunction [J]. J Orthop Trauma, 2019, 33(5): 220-228. doi: 10.1097/BOT.0000000000001437.
[16] 罗惠君, 张卫星, 陈晶莹, 等. 血清TSLP、炎症因子水平与脓毒症患者预后的相关性分析[J]. 中国医学创新, 2020, 17(9): 1-4. LUO Huijun, ZHANG Weixing, CHEN Jingying, et al. Correlation between serum TSLP, inflammatory factors levels and prognosis in sepsis patients [J]. Medical Innovation of China, 2020, 17(9): 1-4.
[17] Jain S, Midha S, Mahapatra SJ, et al. Interleukin-6 significantly improves predictive value of systemic inflammatory response syndrome for predicting severe acute pancreatitis [J]. Pancreatology, 2018, 18(5): 500-506.
[18] 杨珍, 张艳敏, 王倩倩, 等. 微小RNA-103 及RNA-107表达与120例脓毒症患者临床特征及预后的关联分析[J]. 山东大学学报(医学版),2020, 58(12): 77-85. YANG Zhen, ZHANG Yanmin, WANG Qianqian, et al. Correlations of microRNA-103 and microRNA-107 expressions with the clinical characteristics and prognosis of 120 cases of sepsis [J]. Journal of Shandong University(Health Sciences), 2020, 58(12): 77-85.
[19] Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? [J]. J Clin Invest, 2016, 126(1): 23-31.
[20] Peters van Ton AM, Kox M, Abdo WF, et al. Precision immunotherapy for sepsis [J]. Front Immunol, 2018, 5(9): 1926. doi: 10.3389/fimmu.2018.01926. eCollection 2018.
[21] Wang Y, Liu Q, Liu T, et al. Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: A prospective observational study [J]. Medicine(Baltimore), 2018, 97(14): e0356. doi:10.1097/MD. 0000000000010356.
[22] Spoto S, Fogolari M, De Florio L, et al. Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock [J]. Microb Pathog, 2019, 137: 103763. doi: 10.1016/j.micpath.
[23] Lvovschi V, Arnaud L, Parizot C, et al. Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational study [J]. PLoS One, 2011, 6(12): e28870. doi: 10.1371/journal.pone.0028870.

相关文章 15

[1]	江勇,宋剑刚,朱大侠,刘礼剑. 柚皮素通过调控巨噬细胞NLRP3炎症小体活化对脓毒症致急性肺损伤的影响[J]. 山东大学学报 (医学版), 2021, 59(1): 14-21.
[2]	杨珍,张艳敏,王倩倩,陈惠敏,冯强,周少英. 微小RNA-103及RNA-107表达与120例脓毒症患者临床特征及预后的关联分析[J]. 山东大学学报 (医学版), 2020, 58(12): 77-85.
[3]	刘晓,刘志广,范志松,王媛,杨兴肖,孔洁羽,陈俊卓,刘俊霞. 严重脓毒症与脓毒性休克患者预后分析[J]. 山东大学学报（医学版）, 2016, 54(10): 80-84.
[4]	郑加田，朱凯，孙红胜，付敏，潘正论. IL-18和MCP-1基因多态性与类风湿关节炎易感性关系的Meta分析[J]. 山东大学学报（医学版）, 2014, 52(6): 98-104.
[5]	吴学田，王坤，孙树栋. PAI-1基因多态性与烧伤脓毒症的相关性[J]. 山东大学学报（医学版）, 2014, 52(6): 105-107.
[6]	张庆伟1，王春亭2，王启志2，张琳2，王鹏2，孟玫2. 丙酮酸乙酯对脓毒症大鼠小肠黏膜屏障的保护作用及其机制[J]. 山东大学学报（医学版）, 2014, 52(5): 30-34.
[7]	刘新农，展翰翔，胡三元，张光永, 王磊. 血清miR-146a在脓毒症早期诊断中的价值[J]. 山东大学学报(医学版), 2013, 51(9): 92-94.
[8]	白霄1，宋光民1，王维2，赵鑫1，赵宏磊1，赵文杰1，张健1. 单核细胞趋化蛋白-1和NF-κB通路在心脏移植排斥反应中的作用[J]. 山东大学学报(医学版), 2013, 51(11): 1-5.
[9]	唐琳娜，吴大玮，杨洁，卢海宁，张帆，韩辉，郭海鹏. 不同剂量地塞米松对脓毒症小鼠肺组织糖皮质激素受体-α表达及肺损伤的影响[J]. 山东大学学报(医学版), 2013, 51(10): 19-23.
[10]	卢海宁，陈晨，吴大玮，吴玉霞，彭苗苗，杨洁，唐琳娜，郭海鹏. 尿胰蛋白酶抑制剂对脓毒症大鼠早期肺损伤的保护作用[J]. 山东大学学报(医学版), 2012, 50(9): 15-.
[11]	李文元，丁士芳. 急性呼吸窘迫综合征患者预后的危险因素分析[J]. 山东大学学报(医学版), 2012, 50(3): 93-.
[12]	王焕亮1,2，岳寿伟2，徐迎雪1，荣菲1，类维富1，张文华3. 利多卡因对脓毒症大鼠肾组织高迁移率族蛋白表达的影响[J]. 山东大学学报(医学版), 2011, 49(11): 21-.
[13]	徐晖1，张萍1，吴学忠2，张爱荣1. 卵巢上皮性肿瘤MCP-1基因表达的研究[J]. 山东大学学报(医学版), 2010, 48(1): 94-.
[14]	刘粉叶,张继东,胡连海,来丽萍,杨发林 . 益肾活血胶囊对同型半胱氨酸致兔动脉粥样硬化MCP-1mRNA表达及NF-κB活化的影响[J]. 山东大学学报(医学版), 2008, 46(4): 353-356.
[15]	吴玉生,张道杰,李建军,付崇健 . 解毒化瘀方对脓毒症大鼠蛋白C-mRNA表达及血浆蛋白C活性的影响[J]. 山东大学学报(医学版), 2008, 46(4): 382-384.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed